Annual EBITDA
-$3.18 M
+$4.10 M+56.31%
September 30, 2023
Summary
- As of February 7, 2025, UPC annual EBITDA is -$3.18 million, with the most recent change of +$4.10 million (+56.31%) on September 30, 2023.
- During the last 3 years, UPC annual EBITDA has fallen by -$13.82 million (-129.94%).
- UPC annual EBITDA is now -122.38% below its all-time high of $14.23 million, reached on September 30, 2021.
Performance
UPC EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
UPC EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +56.3% | - | - |
3 y3 years | -129.9% | - | - |
5 y5 years | -131.4% | - | - |
UPC EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -122.4% | +56.3% | ||||
5 y | 5-year | -122.4% | +56.3% | ||||
alltime | all time | -122.4% | +56.3% |
Universe Pharmaceuticals EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2023 | -$3.18 M(-56.3%) | - | - |
Sep 2022 | -$7.29 M(-151.2%) | - | - |
Sep 2021 | $14.23 M(+33.8%) | - | - |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2020 | $10.63 M(+4.2%) | - | - |
Sep 2019 | $10.20 M(+0.6%) | - | - |
Sep 2018 | $10.14 M | - | - |
FAQ
- What is Universe Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Universe Pharmaceuticals?
- What is Universe Pharmaceuticals annual EBITDA year-on-year change?
What is Universe Pharmaceuticals annual EBITDA?
The current annual EBITDA of UPC is -$3.18 M
What is the all time high annual EBITDA for Universe Pharmaceuticals?
Universe Pharmaceuticals all-time high annual EBITDA is $14.23 M
What is Universe Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, UPC annual EBITDA has changed by +$4.10 M (+56.31%)